Document Detail

Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats.
MedLine Citation:
PMID:  2899445     Owner:  NLM     Status:  MEDLINE    
1. Cardiac output, its distribution and regional vascular resistances were determined with tracer microspheres in pithed rats in the presence of the angiotensin converting enzyme inhibitor enalapril. The effects of enalapril on the cardiovascular responses elicited by either the alpha 1-adrenoceptor agonist phenylephrine or the alpha 2-adrenoceptor agonist xylazine were determined. 2. Enalapril decreased diastolic and mean blood pressure by decreasing cardiac index and total peripheral resistance. It induced vasodilatation in the kidney, epididimides, epididimidal fat and pancreas/mesentery. Vasoconstriction in the lungs, testes and liver was evident following enalapril administration as well as a decrease in the proportion of cardiac output passing to them, whilst the pancreas and mesentery received a greater proportion of the cardiac output. All the above effects of enalapril were reversed by infusion of angiotensin II at a rate of 75 ng kg-1 min-1. 3. Xylazine increased blood pressure by increasing both cardiac output and total peripheral resistance. Enalapril did not affect the increase in cardiac output caused by xylazine but decreased the effect of the alpha 2-agonist on blood pressure by preventing the increase in total peripheral resistance. Inhibition by enalapril of xylazine-induced vasoconstriction in the kidneys, testes, fat and gastrointestinal tract contributed to the decrease in total peripheral resistance. Enalapril also inhibited xylazine-induced changes in cardiac output distribution to the liver, lungs and heart. All the above effects of enalapril were reversed by infusion of angiotensin II. 4. Enalapril decreased the sustained phase of the pressor response to an infusion of phenylephrine whilst having no effect on the initial peak pressor response to a bolus injection of phenylephrine. Phenylephrine increased both cardiac output and total peripheral resistance and enalapril abolished its effect on total peripheral resistance whilst having no effect on the increase in cardiac output. Enalapril inhibited phenylephrine-induced vasoconstriction in the testes, fat, muscle, spleen and gastrointestinal tract. Enalapril also inhibited phenylephrine-induced changes in cardiac output distribution to the lungs and liver. The infusion of angiotensin II did not fully reverse the inhibitory effect of enalapril either on the phenylephrine-induced increases in diastolic blood pressure or on the vasoconstriction in the fat, spleen and gastrointestinal tract, but did reverse all other effects of enalapril.
M R MacLean; C R Hiley
Related Documents :
7582475 - Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic ag...
16939505 - Acute haemodynamic effects of erythropoietin alone and in combination with dopamine in ...
15985685 - Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dil...
1260975 - The role of arterial baroreceptors in mediating the cardiovascular response to a cardia...
7428385 - Comparison of measured and calculated colloid osmotic pressure of serum and pulmonary e...
6349305 - Crystalloid versus colloid for fluid resuscitation of hypovolemic patients.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  94     ISSN:  0007-1188     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-08-29     Completed Date:  1988-08-29     Revised Date:  2010-04-28    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  449-62     Citation Subset:  IM    
Department of Pharmacology, University of Cambridge.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic alpha-Agonists / pharmacology*
Cardiac Output / drug effects*
Decerebrate State
Enalapril / pharmacology*
Phenylephrine / pharmacology
Rats, Inbred Strains
Vascular Resistance / drug effects*
Xylazine / pharmacology
Grant Support
//Wellcome Trust
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 59-42-7/Phenylephrine; 7361-61-7/Xylazine; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Changes in the activity of adenylate- and guanylate cyclase in different rat tissues after chronic a...
Next Document:  Somatosensory neurons in partially deafferented rat hindlimb granular cortex subsequent to transecti...